Latest Breaking News On - Analytics assay development - Page 1 : comparemela.com

/PRNewswire/ Interius BioTherapeutics, a leading developer of in vivo cell-specific gene medicines, today announced the presentation of preclinical data.

United statesPrnewswire interius biotherapeuticsPhil johnsonDetargeted vesiculovirus fusogenAmerican society of geneAnalytics assay developmentAmerican societyCell therapyAnnual meetingVivo generationEnable targeted in vivo geneEmerging viralVector sheddingSingle intravenous infusionTargeted engineered lentiviralPharmacology toxicology studies